ZYGEL Trademark

Trademark Overview


On Wednesday, February 6, 2019, a trademark application was filed for ZYGEL with the United States Patent and Trademark Office. The USPTO has given the ZYGEL trademark a serial number of 88291596. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 11, 2023. This trademark is owned by Zynerba Pharmaceuticals, Inc.. The ZYGEL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurodevelopmental diseases and disorders, oncological diseases and disorders...
zygel

General Information


Serial Number88291596
Word MarkZYGEL
Filing DateWednesday, February 6, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 11, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 16, 2020

Trademark Statements


Description of MarkThe mark consists of the word "ZYGEL" in purple stylized text to the left of an arrangement of vertical and horizontal, yellow and orange rectangles with rounded ends featuring three purple teardrop shapes and two red teardrop shapes within a grid pattern created by the rectangles.
Goods and ServicesPharmaceutical preparations for the treatment of human and veterinary diseases and disorders, namely, addiction, auditory diseases and disorders, autism, autoimmune diseases and disorders, anxiety, bone diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, cognitive diseases and disorders, dermatological diseases and disorders, diabetic diseases and disorders, endocrine diseases and disorders, gastroenterological diseases and disorders, genetic diseases and disorders, genitourinary diseases and disorders, hepatological diseases and disorders, hormonal diseases and disorders, infectious diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, metabolic diseases and disorders, movement diseases and disorders, muscular diseases and disorders, musculoskeletal diseases and disorders, neurodegenerative diseases and disorders, neurodevelopmental diseases and disorders, oncological diseases and disorders, ophthalmic diseases and disorders, pain, post-traumatic stress, pulmonary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, rheumatological diseases and disorders, psychiatric diseases and disorders, seizure diseases and disorders, sexual dysfunction, speech disorders and diseases, traumatic brain injury, and viral diseases and disorders; Pharmaceutical preparations for the treatment of fragile x syndrome, substance related addiction, autism and autism spectrum disorders, epilepsy, seizure diseases and disorders, anxiety, aphasias, stuttering, post-traumatic stress disorder; all of the foregoing specifically excluding narcolepsy and management of sleep disorders and all of the foregoing solely derived from manufactured synthetic cannabidiol and which do not contain delta-9 tetrahydrocannabinol (THC)
Indication of Colors claimedThe color(s) purple, yellow, orange and red is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 28, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameZynerba Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDevon, PA 19333

Party NameZynerba Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDevon, PA 19333

Trademark Events


Event DateEvent Description
Monday, September 11, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 11, 2023ABANDONMENT - NO USE STATEMENT FILED
Thursday, February 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 22, 2023SOU EXTENSION 5 GRANTED
Monday, February 6, 2023SOU EXTENSION 5 FILED
Wednesday, February 22, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 6, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 24, 2022SOU EXTENSION 4 GRANTED
Friday, June 24, 2022SOU EXTENSION 4 FILED
Friday, June 24, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, February 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 4, 2022SOU EXTENSION 3 GRANTED
Friday, February 4, 2022SOU EXTENSION 3 FILED
Friday, February 4, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, July 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 9, 2021SOU EXTENSION 2 GRANTED
Friday, July 9, 2021SOU EXTENSION 2 FILED
Friday, July 9, 2021SOU TEAS EXTENSION RECEIVED
Thursday, January 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 26, 2021SOU EXTENSION 1 GRANTED
Tuesday, January 26, 2021SOU EXTENSION 1 FILED
Tuesday, January 26, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, August 11, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 16, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 16, 2020PUBLISHED FOR OPPOSITION
Wednesday, May 27, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 6, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 6, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, May 6, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 6, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, May 6, 2020EXAMINERS AMENDMENT -WRITTEN
Thursday, March 12, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 11, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 11, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 17, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 17, 2019NON-FINAL ACTION E-MAILED
Tuesday, September 17, 2019NON-FINAL ACTION WRITTEN
Monday, September 16, 2019ASSIGNED TO EXAMINER
Thursday, April 18, 2019ASSIGNED TO EXAMINER
Thursday, April 18, 2019ASSIGNED TO EXAMINER
Wednesday, April 17, 2019PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, April 9, 2019ASSIGNED TO LIE
Friday, April 5, 2019TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, March 21, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, February 28, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 9, 2019NEW APPLICATION ENTERED